Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2011 and based in Cambridge, UK, Martlet Capital is an early-stage venture capital firm that provides patient capital to startups in deep technology and life sciences. The firm has invested in over 70 companies and is managed by EMV Capital. Their operational strategy has led to several successful exits, including trade sales and IPOs.
Martlet Capital targets pre-seed and seed stage investments in deep technology and life sciences sectors. Their investment thesis emphasizes support for entrepreneurs in artificial intelligence, digital health, genomics, robotics, and sustainable technologies. Typical investments are made in B2B startups with high growth potential.
Martlet Capital's notable portfolio includes companies such as Abcam, a supplier of protein research tools publicly listed on the LSE; Frontier Developments, a video game developer also publicly listed; and Cambridge CMOS Sensors, acquired by AMS AG. Other backed companies include Arachnys, Audio Analytic, and Vantage Power, which was acquired by Allison Transmission.
Email contactus@martletcap.com with your deck to pitch Martlet Capital.
Martlet Capital often leads investment rounds, particularly in their focus areas of deep technology and life sciences.
The firm is open to follow-on investments, supporting portfolio companies as they grow and scale.
Specific fund size details are not publicly available, but the firm has a history of backing over 70 startups since its inception.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.